Diagnosis and Management of Myeloid Malignancies

22nd October 2018

Education Centre (Dept. 17), The Christie, Manchester, M20 4BX

Overview

This study day is designed to increase knowledge on the diagnosis and management of Myeloid Malignancies.

Myeloid disease groups, their treatments, novel therapies, ethics and consent, geriatric hematology and living with myeloid malignancies will be covered by the day.

Intended Audience

This is aimed at staff working in haematology either inpatient or outpatient settings. Also open to nurses, and other allied health professionals.

Learning outcomes

To provide a good knowledge base of the haematological malignancies and the complications and challenges that can occur when caring for them.

Topics covered

  • Myeloproliferative Disorder (MPD)
  • Chronic Myeloid Leukaemia (CML)
  • Acute Myeloid Leukaemia
  • Ethics and consent
  • Geriatric Haematology
  • Living with Myeloid Malignancies

Aim/objectives

The day is designed to increase knowledge on the Diagnosis and management of Myeloid Malignancies.

Key Themes

Discussion and understanding of main myeloid disease groups, their treatments, novel therapies, ethics and consent, geriatric haematology and living with myeloid malignancies

This course has been prepared by and will be delivered by the experts at the Christie School of Oncology

Quick Information
Places are currently available.
Date 22nd October 2018
Venue
Google Maps
Education Centre (Dept. 17), The Christie, Manchester, M20 4BX
Course Fee £60.00 General Admission
Closing Date Places will be offered on a first-come-first-served basis and therefore we are unable to provide a precise closing date.
No of Places Unlimited
Dress code Professional/Semi-formal
Downloads and Links
REGISTER NOW

launch